Rezultati

eNauka >  Results >  Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn's Disease: The OPERA II Study
Title: Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn's Disease: The OPERA II Study
Authors : D'Haens, Geert R; ...; Tarabar, Dino K; ...; (broj, koautora 17)
Issue Date: 2021
Publication: INFLAMMATORY BOWEL DISEASES
ISSN: 1078-0998 Inflammatory Bowel Diseases Search Idenfier
Type: Article
Collation: vol. 28 br. 7 str. 1034-1044
DOI: 10.1093/ibd/izab215
WoS-ID: 000756645800001
Scopus-ID: 2-s2.0-85133855363
PMID: 34427633
PMCID: PMC9247846
URI: https://enauka.gov.rs/handle/123456789/825282
Project: Pfizer
Shire
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21M21

14
SCOPUSTM
12
PubMed CentralTM
14
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.